| Reviews |
 |
|
|
|
|
Reviews to:
Date: Saturday, 19. December 2015
Author: Gast
Review:
I\'m in my first year at university essay writing my favorite subject english The National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending Astellas Pharma’s Xtandi (enzalutamide) for treating hormone relapsed metastatic prostate cancer.
Evaluation:  |
|
|
|
| Shopping Cart |
 |
|
| You do not have any products in your shopping cart yet. |
|
|
Customer group:Guest
|
|
|
|
